Team

Ze’ev Shaked, Ph.D.

zshaked@evestraonkologia.pl
Ze’ev Shaked, Ph.D.

President, Evestra Onkologia, President and CEO, Evestra INC. Dr. Shaked has extensive managerial and pharmaceutical product development experience in commercializing biologics and conventional drugs. He obtained his Ph.D. in Organic Chemistry and Applied Biochemistry from MIT.

Katarzyna Błaszczak-Świątkiewicz, Ph. D. hab

kblaszczak@evestraonkologia.pl
Katarzyna Błaszczak-Świątkiewicz, Ph. D. hab

Development Manager. Participates in the implementation of preclinical and clinical studies and development of the company’s strategy. Responsible for the supervision of quality (GMP and GCP) process. Implements relevant quality assurance (QA) system policies and procedures. She holds a PhD and a postdoctoral degree in pharmaceutical sciences, and completed postgraduate studies in molecular biology at Jagiellonian University. She has participated in courses and internships in UK, EU and USA

Ewelina Mnich, Ph.D.

emnich@evestraonkologia.pl
Ewelina Mnich, Ph.D.

Research Management Specialist. She received her Ph.D. in Biotechnology at University of Copenhagen.

Paweł Kowalczyk, PhD

Clinical Trial Man Specialist. Dr Kowalczyk serves as clinical trial associate as well as provides operation support for ongoing Evestra Onkologia clinical trial. He obtained his PhD in biology.

Łukasz Skrok, Ph.D.

lskrok@evestraonkologia.pl
Łukasz Skrok, Ph.D.

Financial Coordinator. Dr. Skrok manages ongoing finances at Evestra Onkologia. Dr. Skrok manages ongoing finances at Evestra Onkologia. He received PhD in economics on the SGH Warsaw School of Economics

Michael Oettel, Prof.

Scientific Advisor. Dr. Oettel obtained a Ph.D. in Veterinary Parmacology at Leipzig University in Saxony, Germany in 1964. Co-inventor of the progestin, Dienogest, his background includes more than forty years of work in the field of pharmacological management of reproductive functions in domestic animals and humans at organizations such as University Leipzig G.D.R., Academy of Sciences Jena G.D.R./Germany, Jenapharm, Schering AG/Berlin and the Human Reproduction Program of the WHO in Basle-Switzerland. Honors include the National Award for Science and Technology of the GDR and the Prix Casenne 10th Congress of European Association of Gynecologists and Obstetricians (1995, Monaco). He has co-authored 11 scientific textbooks and is editor of the Handbook of Experimental Pharmacology: Estrogens and Antiestrogens (Springer-Verlag, 1999). He is currently a member of the Governing Board of Naari-AG, a pharmaceutical company based in Basel, Switzerland, the Scientific Board of Gynecura-Förderverein Frauengesundheit in Leipzig and the Leibniz-Sozietät. He is a founding member of the Research Center for Medical Engineering and Biotechnology and the Juratorium Innoven e.V., Jena.

Website designed and made by Reddog Systems